FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895593497> ?p ?o ?g. }

• W2895593497 endingPage "523" @default.
• W2895593497 startingPage "517" @default.
• W2895593497 abstract "¹⁷⁷Lu-prostate-specific membrane antigen (PSMA)–617 enables targeted delivery of β-particle radiation to prostate cancer. We determined its radiation dosimetry and relationships to pretherapeutic imaging and outcomes. <b>Methods:</b> Thirty patients with prostate cancer receiving ¹⁷⁷Lu-PSMA-617 within a prospective clinical trial (ACTRN12615000912583) were studied. Screening ⁶⁸Ga-PSMA-11 PET/CT demonstrated high PSMA expression in all patients. After therapy, patients underwent quantitative SPECT/CT at 4, 24, and 96 h. Pharmacokinetic uptake and clearance at a voxel level were calculated and translated into absorbed dose using voxel S values. Volumes of interest were drawn on normal tissues and tumor to assess radiation dose, and a whole-body tumor dose was defined. Correlations between PSMA PET/CT parameters, dosimetry, and biochemical and therapeutic response were analyzed to identify relationships between absorbed dose, tumor burden, and patient physiology. <b>Results:</b> Mean absorbed dose to kidneys, submandibular and parotid glands, liver, spleen, and bone marrow was 0.39, 0.44, 0.58, 0.1, 0.06, and 0.11 Gy/MBq, respectively. Median whole-body tumor-absorbed dose was 11.55 Gy and correlated with prostate-specific antigen (PSA) response at 12 wk. A median dose of 14.1 Gy was observed in patients achieving a PSA decline of at least 50%, versus 9.6 Gy for those achieving a PSA decline of less than 50% (<i>P</i> < 0.01). Of 11 patients receiving a tumor dose of less than 10 Gy, only one achieved a PSA response of at least 50%. On screening PSMA PET, whole-body tumor SUV_mean correlated with mean absorbed dose (<i>r</i> = 0.62), and SUV_max of the parotids correlated with absorbed dose (<i>r</i> = 0.67). There was an inverse correlation between tumor volume and mean dose to the parotids (<i>r</i> = −0.41) and kidneys (<i>r</i> = −0.43). The mean parotid dose was also reduced with increasing body mass (<i>r</i> = −0.41) and body surface area (<i>r</i> = −0.37). <b>Conclusion:</b>¹⁷⁷Lu-PSMA-617 delivers high absorbed doses to tumor, with a significant correlation between whole-body tumor dose and PSA response. Patients receiving less than 10 Gy were unlikely to achieve a fall in PSA of at least 50%. Significant correlations between aspects of screening ⁶⁸Ga-PET/CT and tumor and normal tissue dose were observed, providing a rationale for patient-specific dosing. Reduced salivary and kidney doses were observed in patients with a higher tumor burden. The parotid dose also reduced with increasing body mass and body surface area." @default.
• W2895593497 created "2018-10-12" @default.
• W2895593497 creator A5002564826 @default.
• W2895593497 creator A5020420969 @default.
• W2895593497 creator A5020993128 @default.
• W2895593497 creator A5028575111 @default.
• W2895593497 creator A5029076956 @default.
• W2895593497 creator A5036019382 @default.
• W2895593497 creator A5039260287 @default.
• W2895593497 creator A5044519122 @default.
• W2895593497 creator A5045912081 @default.
• W2895593497 creator A5047242510 @default.
• W2895593497 creator A5063276705 @default.
• W2895593497 creator A5064026461 @default.
• W2895593497 creator A5066214064 @default.
• W2895593497 creator A5070501683 @default.
• W2895593497 creator A5082622296 @default.
• W2895593497 date "2018-10-05" @default.
• W2895593497 modified "2023-10-18" @default.
• W2895593497 title "Dosimetry of ¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes" @default.
• W2895593497 cites W1140456871 @default.
• W2895593497 cites W1490266165 @default.
• W2895593497 cites W1497206380 @default.
• W2895593497 cites W1900676315 @default.
• W2895593497 cites W1964713829 @default.
• W2895593497 cites W1965617754 @default.
• W2895593497 cites W1968405341 @default.
• W2895593497 cites W1973942000 @default.
• W2895593497 cites W1974505317 @default.
• W2895593497 cites W2000340774 @default.
• W2895593497 cites W2005574374 @default.
• W2895593497 cites W2005761045 @default.
• W2895593497 cites W2009041257 @default.
• W2895593497 cites W2011660334 @default.
• W2895593497 cites W2014544986 @default.
• W2895593497 cites W2014999922 @default.
• W2895593497 cites W2017183061 @default.
• W2895593497 cites W2017884723 @default.
• W2895593497 cites W2020804208 @default.
• W2895593497 cites W2053554578 @default.
• W2895593497 cites W2055191735 @default.
• W2895593497 cites W2080677976 @default.
• W2895593497 cites W2105337740 @default.
• W2895593497 cites W2116085429 @default.
• W2895593497 cites W2127498681 @default.
• W2895593497 cites W2133267052 @default.
• W2895593497 cites W2134364976 @default.
• W2895593497 cites W2154289925 @default.
• W2895593497 cites W2154474830 @default.
• W2895593497 cites W2163857638 @default.
• W2895593497 cites W2167090712 @default.
• W2895593497 cites W2278465954 @default.
• W2895593497 cites W2302508993 @default.
• W2895593497 cites W2303817381 @default.
• W2895593497 cites W2312724636 @default.
• W2895593497 cites W2326657743 @default.
• W2895593497 cites W2346293763 @default.
• W2895593497 cites W2397136240 @default.
• W2895593497 cites W2415973042 @default.
• W2895593497 cites W2467018059 @default.
• W2895593497 cites W2516454849 @default.
• W2895593497 cites W2523192478 @default.
• W2895593497 cites W2532226140 @default.
• W2895593497 cites W2544324436 @default.
• W2895593497 cites W2728713011 @default.
• W2895593497 cites W2799931007 @default.
• W2895593497 doi "https://doi.org/10.2967/jnumed.118.219352" @default.
• W2895593497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30291192" @default.
• W2895593497 hasPublicationYear "2018" @default.
• W2895593497 type Work @default.
• W2895593497 sameAs 2895593497 @default.
• W2895593497 citedByCount "251" @default.
• W2895593497 countsByYear W28955934972018 @default.
• W2895593497 countsByYear W28955934972019 @default.
• W2895593497 countsByYear W28955934972020 @default.
• W2895593497 countsByYear W28955934972021 @default.
• W2895593497 countsByYear W28955934972022 @default.
• W2895593497 countsByYear W28955934972023 @default.
• W2895593497 crossrefType "journal-article" @default.
• W2895593497 hasAuthorship W2895593497A5002564826 @default.
• W2895593497 hasAuthorship W2895593497A5020420969 @default.
• W2895593497 hasAuthorship W2895593497A5020993128 @default.
• W2895593497 hasAuthorship W2895593497A5028575111 @default.
• W2895593497 hasAuthorship W2895593497A5029076956 @default.
• W2895593497 hasAuthorship W2895593497A5036019382 @default.
• W2895593497 hasAuthorship W2895593497A5039260287 @default.
• W2895593497 hasAuthorship W2895593497A5044519122 @default.
• W2895593497 hasAuthorship W2895593497A5045912081 @default.
• W2895593497 hasAuthorship W2895593497A5047242510 @default.
• W2895593497 hasAuthorship W2895593497A5063276705 @default.
• W2895593497 hasAuthorship W2895593497A5064026461 @default.
• W2895593497 hasAuthorship W2895593497A5066214064 @default.
• W2895593497 hasAuthorship W2895593497A5070501683 @default.
• W2895593497 hasAuthorship W2895593497A5082622296 @default.
• W2895593497 hasBestOaLocation W28955934971 @default.
• W2895593497 hasConcept C121608353 @default.
• W2895593497 hasConcept C126322002 @default.
• W2895593497 hasConcept C126838900 @default.

• next